Bile acids in drug induced liver injury: Key players and surrogate markers
- PMID: 26874804
- DOI: 10.1016/j.clinre.2015.12.017
Bile acids in drug induced liver injury: Key players and surrogate markers
Abstract
Bile acid research has gained great momentum since the role of bile acids as key signaling molecules in the enterohepatic circulation was discovered. Their physiological function in regulating their own homeostasis, as well as energy and lipid metabolism make them interesting targets for the pharmaceutical industry in the context of diseases such as bile acid induced diarrhea, bile acid induced cholestasis or nonalcoholic steatohepatitis. Changes in bile acid homeostasis are also linked to various types of drug-induced liver injury (DILI). However, the key question whether bile acids are surrogate markers for monitoring DILI or key pathogenic players in the onset and progression of DILI is under intense investigation. The purpose of this review is to summarize the different facets of bile acids in the context of normal physiology, hereditary defects of bile acid transport and DILI.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats.Toxicol Appl Pharmacol. 2013 Apr 1;268(1):79-89. doi: 10.1016/j.taap.2013.01.018. Epub 2013 Jan 27. Toxicol Appl Pharmacol. 2013. PMID: 23360887
-
Organic solute transporter OSTα/β is overexpressed in nonalcoholic steatohepatitis and modulated by drugs associated with liver injury.Am J Physiol Gastrointest Liver Physiol. 2018 May 1;314(5):G597-G609. doi: 10.1152/ajpgi.00310.2017. Epub 2018 Feb 8. Am J Physiol Gastrointest Liver Physiol. 2018. PMID: 29420067 Free PMC article.
-
Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis.Toxicol Appl Pharmacol. 2015 Mar 15;283(3):178-86. doi: 10.1016/j.taap.2015.01.020. Epub 2015 Feb 3. Toxicol Appl Pharmacol. 2015. PMID: 25655198
-
Bile acids and gestation.Mol Aspects Med. 2017 Aug;56:90-100. doi: 10.1016/j.mam.2017.05.003. Epub 2017 May 18. Mol Aspects Med. 2017. PMID: 28506676 Review.
-
The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.Handb Exp Pharmacol. 2011;(201):205-59. doi: 10.1007/978-3-642-14541-4_5. Handb Exp Pharmacol. 2011. PMID: 21103971 Review.
Cited by
-
Farnesoid X receptor contributes to oleanolic acid-induced cholestatic liver injury in mice.J Appl Toxicol. 2022 Aug;42(8):1323-1336. doi: 10.1002/jat.4298. Epub 2022 Feb 23. J Appl Toxicol. 2022. PMID: 35128688 Free PMC article.
-
Phase I study of PF‐04895162, a Kv7 channel opener, reveals unexpected hepatotoxicity in healthy subjects, but not rats or monkeys: clinical evidence of disrupted bile acid homeostasis.Pharmacol Res Perspect. 2019 Feb;7(1):e00467. doi: 10.1002/prp2.467. Pharmacol Res Perspect. 2019. PMID: 30784208 Free PMC article. Clinical Trial.
-
Untargeted Metabolomic Analysis Combined With Multivariate Statistics Reveal Distinct Metabolic Changes in GPR40 Agonist-Treated Animals Related to Bile Acid Metabolism.Front Mol Biosci. 2021 Jan 15;7:598369. doi: 10.3389/fmolb.2020.598369. eCollection 2020. Front Mol Biosci. 2021. PMID: 33521051 Free PMC article.
-
Functional metabolomics characterizes the contribution of farnesoid X receptor in pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.Arch Toxicol. 2024 Aug;98(8):2557-2576. doi: 10.1007/s00204-024-03762-x. Epub 2024 May 4. Arch Toxicol. 2024. PMID: 38703205
-
Development and Validation of a Highly Sensitive LC-MS/MS Method for the Analysis of Bile Acids in Serum, Plasma, and Liver Tissue Samples.Metabolites. 2020 Jul 9;10(7):282. doi: 10.3390/metabo10070282. Metabolites. 2020. PMID: 32660078 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical